Attending the DIA China Conference in 2024 was an invaluable opportunity for Expecto that provided us with significant insights, networking opportunities, and the latest advancements in the pharmaceutical and healthcare industries. Throughout the conference, we had the chance to engage with key stakeholders, participate in thought-provoking discussions, and gain a deeper understanding of the regulatory landscape and emerging trends shaping the industry in China and beyond.
Participating in this conference has provided us with invaluable knowledge, insights, and connections that will significantly enhance our capabilities and bolster our growth within the ever-changing Pharmaceutical, Biotech, and Healthcare landscape in China. Expecto is fully committed to actively contributing to this dynamic journey ahead.
Sachin Patil Danny Soon Tam C. Nguyen Jo Zhang, PMP
#DIACHINA2024 #Conference #Networking #Innovation #Knowledge #Learnings #Pharma #Clinicaltrials #Regulatory #Healthcare #Expecto
